
|Articles|April 1, 2018 (Updated: November 15, 2020)
- Pharmaceutical Executive-04-01-2018
- Volume 38
- Issue 4
Pharmaceutical Executive, April 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Rewriting Pharma’s Talent Blueprintalmost 8 years ago
Trading Big Pharma for Small Startupalmost 8 years ago
HEOR Education: Evolving the Skill Setalmost 8 years ago
Drug Marketing and Advertising Under Firealmost 8 years ago
A Watchful Eye on AIalmost 8 years ago
The New Talent Trajectoryalmost 8 years ago
HBA's Woman of the Year 2018almost 8 years ago
The New (Augmented) Reality in the Life Sciencesalmost 8 years ago
Med Affairs Building Up its Strategic Musclealmost 8 years ago
The Top Barriers to Patient PersistenceNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
5




